tiprankstipranks
Moleculin Biotech (MBRX)
NASDAQ:MBRX
US Market
MBRX
Moleculin Biotech
RESEARCH TOOLSreports

Moleculin Biotech (MBRX) Stock News & Sentiment

1,935 Followers
Moleculin Advances MIRACLE Trial, Prepares Interim AML Readout
Premium
Company Announcements
Moleculin Advances MIRACLE Trial, Prepares Interim AML Readout
10d ago
8K
MBRX
Moleculin Biotech: Attractive Risk/Reward Ahead of Pivotal Annamycin Phase 3 Readout Supports Buy Rating and $10 Target
Premium
Ratings
Moleculin Biotech: Attractive Risk/Reward Ahead of Pivotal Annamycin Phase 3 Readout Supports Buy Rating and $10 Target
13d ago
MBRX
Moleculin Biotech Updates Investors with New Corporate Presentation
Premium
Company Announcements
Moleculin Biotech Updates Investors with New Corporate Presentation
14d ago
8K
MBRX
MBRX Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
MBRX Earnings this Week: How Will it Perform?
16d ago
MBRX
Moleculin Biotech Raises Capital via Inducement Warrant Agreements
Premium
Company Announcements
Moleculin Biotech Raises Capital via Inducement Warrant Agreements
1M ago
8K
MBRX
Early Efficacy Signal in Annamycin’s Phase 3 MIRACLE Trial Supports Buy Rating on Moleculin
Premium
Ratings
Early Efficacy Signal in Annamycin’s Phase 3 MIRACLE Trial Supports Buy Rating on Moleculin
1M ago
MBRX
Moleculin Biotech Issues New Investor Corporate Presentation
Premium
Company Announcements
Moleculin Biotech Issues New Investor Corporate Presentation
1M ago
8K
MBRX
More MBRX News >

MBRX News on the Web

Moleculin Biotech management to meet with Maxim
TipRanks News
Neutral
Moleculin Biotech files to sell 6.37M shares of common stock for holders
TipRanks News
Neutral
Analysts Offer Insights on Healthcare Companies: Moleculin Biotech (MBRX) and Achieve Life Sciences (ACHV)
TipRanks News
Bullish
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks News
Bullish
Moleculin Biotech announces enrollment milestone in MIRACLE trial
TipRanks News
Bullish
Moleculin Advances MIRACLE Trial, Prepares Interim AML Readout
TipRanks News
Neutral
Moleculin Biotech: Attractive Risk/Reward Ahead of Pivotal Annamycin Phase 3 Readout Supports Buy Rating and $10 Target
TipRanks News
Bullish
Moleculin Biotech Updates Investors with New Corporate Presentation
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
MBRX
Sector Average
Media Buzz
This Week2 articles
Weekly Average2.75 articles
News Sentiment
This Week50%
Sector Average63%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is MBRX’s Media Buzz Sentiment?
2 articles about MBRX were published this week. In an average week, 2.75 articles are published.
    What is MBRX’s weekly average amount of articles?
    In an average week, 2.75 articles about MBRX are published.
      What is MBRX’s News Sentiment?
      50% of articles about MBRX were positive this week, compared to its sector average of 63%.
        Healthcare Stocks that are Trending in the News
        6699Angelalign Technology Inc.
        AGIOAgios Pharma
        DMACDiamedica Therapeutics
        DBVTDBV Technologies SA - American
        ITRMIterum Therapeutics
        Showing the stocks with the most bullish news sentiment over the past week